Abstract

Abstract submission has closed. Thank you for your submission.

Acceptance notification

Acceptance notifications were sent to registered email addresses on June 14, 2024. To view the list of accepted abstracts, please click the button below.

*Please be informed that the presentation numbers for the poster session have been updated. Presentations numbered P-01 to P-99 are now renumbered as P-001 to P-099.

Accepted Abstracts List

Abstract Submission

Abstract submission will start on Thursday, February 15, 2024 (JST)
Abstract submission deadline: Friday, March 29, 2024 (JST)
* There will be no extension of submission deadline.
* Indicated time follows Japan standard time
Modification/deletion of submitted abstracts must be done by 23:59, Tuesday, April 2, 2024 (JST)
Abstracts should be related to the kidneys of the elderly, age-related renal changes, and renal replacement therapy in the elderly.
Abstract body should be less than 3,400 characters.
Spaces are included in the character count (tables and graphs do not count as characters if inserted as an image). Abstract authors/co-authors’ names and affiliations, do not count towards the 3,400-character allowance.
Required Headings: Background and Aims/Methods/Results/Discussion and Conclusion
Or, Background/Cases/Discussion and Conclusion in Case Series/Reports.
Abstract title should be less than 200 characters including spaces.
Figure and/or Chart can be uploaded in image file and it must be in JPEG, PNG or GIF format (uploaded images cannot exceed 1.0 MB).
Case Series/Case Reports that present novel hypotheses, pathologies, or treatments are welcome.
The maximum number of abstract co-authors that can be listed in an abstract is 15.
The maximum number of abstract authors’ institution that can be listed in an abstract is 11.
Abstracts must be submitted in English.
This symposium is on-site only, and accepted abstracts will be presented as posters at the moderated poster session on site.
Content of Work Agreement: The presenting author must confirm that all co-authors agree with the submission and content of the abstract. The JSN and the ERA cannot be deemed responsible for any infringement of this rule.
Copyright: All authors of abstracts grant the JSN and the ERA for an indefinite period of time, without territorial limitations and without any right to compensation, the right to make the abstract available to the public as well as to all other users, through the JSN and the ERA website and any other websites operated by the JSN and the ERA as well as via social media or any other website related to medical issues.
Ethical Declaration:The JSN and the ERA are strongly committed towards ethics in all the fields of interest of the Association. It strongly supports both the Declaration of Helsinki (regarding research ethics done on humans) as well as the Declaration of Istanbul (regarding organ trafficking and transplant tourism). Abstracts may be removed from the program if there is a clear evidence of violation of these declarations.
Conflict of Interest Disclosure:You are requested to show whether there are any conflicts of interest on medical researches and publications by clicking a check box when your abstract submission. Please refer to the detailed regulations.
JSN/ERA Symposium Award 2024 – Best Presentation Award and Outstanding Abstract Award: Outstanding abstracts from the applicants will be selected by the JSN and the ERA Award Committee, and will be presented as oral sessions.

Abstract submission site

Newly submission has closed on Friday, March 29, 2024

Confirmation/modification/deletion period has ended on Tuesday, April 2, 2024 (JST)

*Indicated time follows Japan standard time

Platinum Sponsor

Silver Sponsor

Abstract

Acceptance notification

Abstract Submission

Category

Abstract submission site